Investing.com - Takeda Pharma ADR reported on Thursday fourth quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Takeda Pharma ADR announced earnings per share of ¥0.1618 on revenue of ¥7.88B. Analysts polled by Investing.com anticipated EPS of ¥0.2206 on revenue of ¥7.27B.
Takeda Pharma ADR shares are up 7.19% from the beginning of the year and are trading at ¥14.61 , down-from-52-week-high.They are outperforming the EUR/USD which is down 0% from the start of the year.
Takeda Pharma ADR follows other major Healthcare sector earnings this month
Takeda Pharma ADR's report follows an earnings beat by J&J on Tuesday, January 25, 2022, who reported EPS of ¥2.13 on revenue of ¥24.8B, compared to forecasts EPS of ¥2.12 on revenue of ¥25.28B.
UnitedHealth had beat expectations on Wednesday, January 19, 2022 with fourth quarter EPS of ¥4.48 on revenue of ¥73.74B, compared to forecast for EPS of ¥4.3 on revenue of ¥72.98B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar